Distribution of endothelial nitric oxide synthase gene polymorphisms in Turkish population

Journal of Investigative Medicine

Volumn 57, Issue 7, 2009, Pages 769-776

  Sinici, Incilay ^a   Karahan, Sevilay ^a   Atalar, Enver ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Enos gene; Exon 7; Nitric oxide; Promoter; VNTR intron

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ALLELE; ARTICLE; BASE PAIRING; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; EXON; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; LINKAGE ANALYSIS; MALE; NORMAL HUMAN; TURKEY (REPUBLIC);

5' FLANKING REGION; ADULT; AGED; BASE SEQUENCE; DNA PRIMERS; EXONS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TURKEY; YOUNG ADULT;

EID: 74249096963     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e3181b91bbd     Document Type: Article

References (43)

1. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med. 1997;48:489-509.
2. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996; 271(5 pt 1): C1424-C1437.
3. Moncada S, Higgs A. The L-arginineYnitric oxide pathway. N Engl J Med. 1993;329(27):2002-2012.
4. Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268(23):17478-17488.
5. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis. 2001;154(3):521-527.
6. Hou L, Osei-Hyiaman D, Yu H, et al. Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients. Neurology. 2001;56:490-496.
7. Yahashi Y, Kario K, Shimada K, et al. The 27-bp repeat polymorphism in intron 4 of the endothelial cell nitric oxide synthase gene and ischemic stroke in a Japanese population. Blood Coagul Fibrinolysis. 1998;9:405-409.
8. Casas JP, Cavalleri GL, Bautista LE, et al. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol. 2006;164:921-935.
9. Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405(6788):847-856.
10. Tanus-Santos JE, Desai M, Flockhart DA. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics. 2001;11(8):719-725.
11. Tanus-Santos JE, Desai M, Deak LR, et al. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics. 2002;12:407-413.
12. Akar N, Akar E, Cin S, et al. Endothelial nitric oxide synthase intron 4, 27 bp repeat polymorphism in Turkish patients with deep vein thrombosis and cerebrovascular accidents. Thromb Res. 1999; 94(1):63-64.
13. Cine N, Hatemi AC, Erginel-Unaltuna N. Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients. Clin Genet. 2002;61(1):66-70.
14. Karasneh JA, Hajeer AH, Silman A, et al. Polymorphisms in the endothelial nitric oxide synthase gene are associated with Beh0et's disease. Rheumatology (Oxford). 2005;44(5):614-617.
15. Matyar S, Attila G, Acartürk E, et al. eNOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey. Clin Chim Acta. 2005;354(1-2):153-158. (Pubitemid 40320686)
16. Olcay A, Ekmekci CG, Ozbek U, et al. Negative association of endothelial nitric oxide gene polymorphism with hypertension in Turkish patients: effect of ecNOS polymorphism on left ventricular hypertrophy. Cardiovasc Ultrasound. 2006;4:33.
17. Agirbasli D, Agirbasli M, Williams SM, et al. Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients. Coron Artery Dis. 2006;17(5):413-417.
18. Dursun H, Noyan A, Matyar S, et al. Endothelial nitric oxide synthase gene intron 4 a/b VNTR polymorphism in children with APSGN. Pediatr Nephrol. 2006;21(11):1661-1665.
19. Celik U, Yildizdaz D, Alhan E, et al. Genetic dilemma: eNOS gene intron 4a/b VNTR polymorphism in sepsis and its clinical features in Turkish children. Turk J Pediatr. 2008;50(2):114-119.
20. Tangurek B, Ozer N, Sayar N, et al. The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population. Heart Vessels. 2006;21(5):285-290.
21. Ciftoi C, Melil S, Cebi Y, et al. Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease. Lipids Health Dis. 2008;7:5.
22. Akar N, Akar E, Deda G, et al. No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology. 2000;55(3):460-461.
23. Aras O, Hanson NQ, Bakanay SM, et al. Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population. Thromb Haemost. 2002;87(2): 347-349.
24. Afrasyap L, Ozturk G. NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population. Acta Biochim Biophys Sin (Shanghai). 2004;36(10):661-666.
25. Cam SF, Sekuri C, Tengiz I, et al. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res. 2005;116(4):287-292.
26. Kara N, Senturk N, Gunes SO, et al. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphism (glu298asp) with Beh0et's disease in the Turkish population. Arch Dermatol Res. 2006;297(10):468-471.
27. Berdeli A, Sekuri C, Sirri Cam F, et al. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta. 2005;351(1-2):87-94.
28. Alazehirli B, Demiryürek S, Arica E, et al. No evidence for an association between the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and fibromyalgia syndrome. Rheumatol Int. 2007;27(3):275-280.
29. Oksel F, Keser G, Ozmen M, et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism is associated with Beh0et's disease. Clin Exp Rheumatol. 2006;5(suppl 42):S79-S82.
30. Balat A, Alasehirli B, Oguzkan S, et al. Nitric oxide synthase gene polymorphisms in children with primary nocturnal enuresis: a preliminary study. Ren Fail. 2007;29(1):79-83. (Pubitemid 46321352)
31. Guldiken B, Sipahi T, Guldiken S, et al. Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke. Mol Biol Rep. 2008;
32. Senturk N, Kara N, Aydin F, et al. Association of eNOS gene polymorphism (Glu298Asp) with psoriasis. Dermatol Sci. 2006;44(1):52-55.
33. Ozdemir FN, Basaran O, Ozdemir BH, et al. Angiotensin-converting enzyme and endothelial constitutive nitric oxide synthase polymorphisms in Turkish renal transplant population and possible influence on renal artery atherosclerosis and graft survival. Transplant Proc. 2005;37(7):2929-2932.
34. Marroni AS, Metzger IF, Souza-Costa DC, et al. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide. 2005;12(3):177-182.
35. Tanus-Santos JE, Casella-Filho A. Endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis. Hypertension. 2007;49:E1.
36. Rubin EM, Tall A. Perspectives for vascular genomics. Nature. 2000;407(6801):265-269.
37. Tesauro M, Thomspon WC, Rogliani P, et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci. 2000;97:2832-2835.
38. Salvarani C, Boiardi L, Casali B, et al. Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease. J Rheumatol. 2002;29(3):535-540.
39. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511-2517.
40. Sareli P, Radevski IV, Valtchanova ZP, et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med. 2001;161:965-971.
41. Li R, Lyn D, Lapu-Bula R, et al. Relation of endothelial nitric oxide synthase gene to plasma nitric oxide level, endothelial function, and blood pressure in African Americans. Am J Hypertens. 2004;17:560-567.
42. Wood AJ. Racial differences in the response to drugsVpointers to genetic differences. N Engl J Med. 2001;344:1393-1396.
43. Baráth A, Endreffy E, Bereczki C, et al. Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension. Acta Physiol Hung. 2007;94(1-2):49-66.